What makes 18F-MAPP a promising translational candidate to noninvasively monitor MPO activity and inflammation in patients, and potentially, knowing MPO’s role in NASH, to monitor NASH pathogenesis. This evidence concerns the gene MPO and metabolic dysfunction-associated steatohepatitis.